You are here

Third Harmonic Bio

Third Harmonic, latest victim of raised liver enzymes, shutters trial and sees shares slide

Fierce Biotech

Fri, 12/16/22 - 10:20 am

Third Harmonic Bio

clinical trials

chronic inducible urticaria

The biopharma flotation remains a rare beast

EP Vantage

Tue, 10/4/22 - 10:40 am

Maia Biotechnology

Third Harmonic Bio

Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering

BioPharma Dive

Wed, 09/14/22 - 10:11 am

Third Harmonic Bio

Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab

Fierce Biotech

Wed, 08/24/22 - 10:40 pm

Third Harmonic Bio

inflammatory diseases

Financing roundup: Electra’s Star debut, Kallyope’s cash, Memo’s money & more

MedCity News

Tue, 02/22/22 - 10:48 am

Electra Therapeutics

Memo Therapeutics

Centauri Therapeutics

Third Harmonic Bio

Third Harmonic Bio Launches to Advance the Next Wave of Medicine for Allergy and Inflammation

BioSpace

Wed, 02/16/22 - 10:51 am

Third Harmonic Bio

chronic urticaria